Heart
Rheumatic heart disease
Acute rheumatic fever follows group A streptococcal pharyngitis and can inflame all layers of the heart; repeated attacks scar the valves, above all the mitral valve, decades later.
Causes and risk factors
- Group A streptococcal pharyngitis, 10 days to 6 weeks earlier
- Molecular mimicry: an immune cross-reaction with the streptococcal M protein
- Recurrent attacks with further streptococcal infections
Gross pathology
- Acute: small verrucous vegetations (about 2 mm) along the valve closure line, which rarely embolise.
- Chronic: thickened, scarred mitral valve with a narrow “fish-mouth” opening, and short, thick chordae tendineae.
- Stenosis usually predominates; the left atrium enlarges.
Under the microscope
- Aschoff nodules in the myocardial interstitium: perivascular collections of mononuclear cells.
- Aschoff giant cells (two or more nuclei with prominent nucleoli) and Anichkov myocytes with long, thin nuclei.
- Endocardium, myocardium and epicardium can all be involved: pancarditis.
How it develops
- 10 days to 6 weeks after pharyngitis: Antibodies to streptococcal antigens cross-react with heart tissue.
- Acute rheumatic fever: pancarditis, with fever, polyarthritis, subcutaneous nodules and erythema marginatum (major Jones criteria).
- Recurrent attacks inflame and scar the valves.
- Decades: Chronic valvulitis: mitral stenosis (with or without regurgitation), left atrial enlargement and slowly appearing symptoms.
Complications
- Mitral stenosis and regurgitation; mitral and aortic valves together next most often
- Left atrial enlargement, with mural thrombus and systemic embolism; it can press on the oesophagus and cause dysphagia
- Death from myocarditis in about 1% of acute rheumatic fever
Investigations
- Echocardiography
- Thickened, fused mitral leaflets with a narrowed opening and an enlarged left atrium; other valves may be involved.
- Evidence of streptococcal infection
- In acute rheumatic fever: a raised antistreptolysin O (ASO) titre or a positive throat culture.
- Electrocardiogram
- Atrial fibrillation, common once the left atrium is enlarged.
Drug treatment
- Oral anticoagulants (warfarin and the direct oral anticoagulants): Tablets that prevent clots: warfarin blocks the vitamin K cycle; the direct oral anticoagulants (DOACs) inhibit thrombin or factor Xa. Used for venous thromboembolism and to prevent stroke in atrial fibrillation.
- Penicillins: β-Lactam antibiotics that stop bacteria cross-linking their cell wall: bactericidal and safe, they treat streptococcal and many other infections and prevent recurrent rheumatic fever.
Drugs to avoid or use with care
- Oral anticoagulants (warfarin and the direct oral anticoagulants) (Contraindicated): DOACs failed to prevent valve thrombosis; warfarin is used.
- Dopamine agonists (for pituitary tumours) (Use with care): Activation of 5-HT2B receptors can thicken the valves.
Anatomy involved
Connected topics
Written from
- Robbins and Cotran Atlas of Pathology, 3rd ed., Ch. 2, The Heart, pp. 43–45, figs 2-48 to 2-54
Educational reference. Not medical advice, diagnosis or treatment.